GLP-1 medications were linked to a 31% lower risk of type 2 diabetes and 41% lower all-cause mortality compared to metformin in adults with prediabetes and obesity, a study found.
GLP-1 medications were linked to a 31% lower risk of type 2 diabetes and 41% lower all-cause mortality compared to metformin in adults with prediabetes and obesity, a study found.
